Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-15
2005-03-15
Ford, John M. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S186000, C514S187000, C514S188000, C514S230500, C514S266210, C514S300000, C514S311000, C546S114000, C546S115000, C546S116000, C546S117000, C546S118000, C546S122000, C546S134000, C546S192000, C546S193000, C546S246000, C546S247000, C546S257000, C546S264000, C546S269700, C546S271400, C546S272700
Reexamination Certificate
active
06867217
ABSTRACT:
The invention relates to substituted polycyclic aryl and heteroaryl pyridone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
REFERENCES:
patent: 4489096 (1984-12-01), Terao et al.
patent: 4851413 (1989-07-01), Terao et al.
patent: 4992469 (1991-02-01), Ozawa et al.
patent: 5008267 (1991-04-01), Katakami et al.
patent: 5304658 (1994-04-01), Terao et al.
patent: 5441960 (1995-08-01), Bernstein et al.
patent: 5656645 (1997-08-01), Tamura et al.
patent: 5658930 (1997-08-01), Tamura et al.
patent: 5668289 (1997-09-01), Sanderson et al.
patent: 5741819 (1998-04-01), Illig et al.
patent: 5792779 (1998-08-01), Sanderson et al.
patent: 5861380 (1999-01-01), Gyorkos et al.
patent: 5866573 (1999-02-01), Sanderson et al.
patent: 5869487 (1999-02-01), Coburn et al.
patent: 5872138 (1999-02-01), Naylor-Olsen et al.
patent: 6011158 (2000-01-01), Tamura et al.
patent: 6037356 (2000-03-01), Lu et al.
patent: 6180627 (2001-01-01), Blagg et al.
patent: 6326492 (2001-12-01), Wang et al.
patent: 6610492 (2003-08-01), Stanton et al.
patent: 198 51 421 (2000-05-01), None
patent: 0 354 495 (1990-02-01), None
patent: 826 671 (1998-03-01), None
patent: 936 216 (1999-08-01), None
patent: 940 400 (1999-09-01), None
patent: 997 474 (2000-05-01), None
patent: 528 633 (2000-10-01), None
patent: P300545 (1993-11-01), None
patent: 210056 (1995-01-01), None
patent: WO 9321214 (1993-10-01), None
patent: WO 9618644 (1996-06-01), None
patent: WO 9633974 (1996-10-01), None
patent: WO 9639380 (1996-12-01), None
patent: WO 9640100 (1996-12-01), None
patent: WO 9701338 (1997-01-01), None
patent: WO 9730708 (1997-08-01), None
patent: WO 9740024 (1997-10-01), None
patent: WO 9746207 (1997-12-01), None
patent: WO 9808840 (1998-03-01), None
patent: WO 9809949 (1998-03-01), None
patent: WO 9809987 (1998-03-01), None
patent: WO 9810763 (1998-03-01), None
patent: WO 9816525 (1998-04-01), None
patent: WO 9816547 (1998-04-01), None
patent: WO 9817274 (1998-04-01), None
patent: WO 9831670 (1998-07-01), None
patent: WO 9842342 (1998-10-01), None
patent: WO 9847876 (1998-10-01), None
patent: WO 9850420 (1998-11-01), None
patent: WO 9900121 (1999-01-01), None
patent: WO 9900126 (1999-01-01), None
patent: WO 9900128 (1999-01-01), None
patent: WO 9911267 (1999-03-01), None
patent: WO 9926920 (1999-06-01), None
patent: WO 9926926 (1999-06-01), None
patent: WO 9936426 (1999-07-01), None
patent: WO 9943660 (1999-09-01), None
patent: WO 9948892 (1999-09-01), None
patent: WO 9959591 (1999-11-01), None
patent: WO 9961442 (1999-12-01), None
patent: WO 9962538 (1999-12-01), None
patent: WO 9964446 (1999-12-01), None
patent: WO 0018762 (2000-04-01), None
patent: WO 0026210 (2000-05-01), None
patent: WO 0026211 (2000-05-01), None
patent: WO 0032574 (2000-06-01), None
patent: WO 0039102 (2000-07-01), None
patent: WO 0069826 (2000-11-01), None
patent: WO 0069832 (2000-11-01), None
patent: WO 0069833 (2000-11-01), None
Majerus, et al. “Anticoagulant, Thrombolytic, and Antiplatelet Drugs.” Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition, 1996, pp. 1341-1359, McGraw-Hill, New York.
Handin, R., “Bleeding and Thrombosis.” Harrison's Principles of Internal Medicine, 12th Edition, 1991, pp. 348-353, McGraw-Hill, Inc., New York.
Sanderson et al., “L-373,890, An Achiral, Noncovalent, Subnamomolar Thrombin Inhibitor.” Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 12, pp. 1497-1500, 1997.
Darvas, F. et al., “Investigation of the common mechanism of action of antibacterial compounds containing gamma-pyridone-beta-carboxylic acid structure by principal component”, Retrieved from STN Database accession No. 93:1350, XP002182132, abstract, Arzneim.-Forsch. (1979), 22(9), 1334-9.
Patel et al., “Directed aminomethylation of 3-Hydroxy-2(1Hpyridinones and -3hydroxy-4(1H)-pyridinones: Synthesis of iso-deferiprone.” Tetrahedron, Elsevier Science Publishers, Amsterdam, NL, vol. 52, No. 5, 1996, XP004104485.
Trecourt, et al., “First synthesis of (+/-) harizianopyridone by metalation of polysubstituted O-pyridylcarbamates.” Retrieved from STN Database accession No. 123:256397, XP002182410 abstract, J. Heterocycl. Chem (1995), 32(4), 1117-4.
Rauch, et al., Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences, Annals of Internal Medicine, 2001, pp. 224-233, vol. 134—No. 3.
Van Aken, et al., Anticoagulation: The Present and Future, Clin. Appl. Thrombosis/Hemostasis, 2001, pp. 195-204, vol. 7—No. 3.
Coburn, C.A., “Small-molecule direct thrombine inhibitors 1997-2000.” Expert Opinions on Therapeutic Patents, 2001, 721-738, vol. 11, No. 5.
XP-002172033—Kohama et al., “Preparation of Piperidinyloxyacetylaminobenzoylalanine Derivatives and Analogs as Antithrombotics.” JP 07,233,148., CA, vol. 124, ABS #117979, 1996.
Majerus, et al, “Anticoagulant, Thrombolytic, and Antiplatlet Drugs.” Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition, 1996, pp. 1341-1359, McGraw-Hill, New York.
XP-002187583—Moerner, Hoppe-Seyler's Z. Physiol. Chem., 69, 1910; 357, 1990.
Tulinsky et al., “Novel Asymmetric Synthesis of Atropisomeric 6-Aryle Pyrazinones vis an Unusual Chirality Transfer Process.” J. Org. Chem., 1999, pp. 93-100, vol. 64, No. 1.
Novelty Search Report of P0201996 dated Nov. 28, 2002.
Hamme, II Ashton T.
Rueppel Melvin L.
South Michael S.
Zeng Qingping
Ford John M.
Pharmacia Corporation
Truong Tamthom N.
LandOfFree
Substituted polycyclic aryl and heteroaryl pyridones useful... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted polycyclic aryl and heteroaryl pyridones useful..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted polycyclic aryl and heteroaryl pyridones useful... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3445871